Advanced Triple Negative Breast Cancer (TNBC) With High TAMs Clinical Trials

Advanced Triple Negative Breast Cancer (TNBC) With High TAMs

Explore clinical trials studying Advanced Triple Negative Breast Cancer (TNBC) With High TAMs. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Advanced Triple Negative Breast Cancer (TNBC) With High TAMs trial results

Completed

Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)

NCT02435680

Conditions: Advanced Triple Negative Breast Cancer (TNBC) With High TAMs
Locations: Highlands Oncology Group Fayetteville, Arkansas, United States

Massachusetts General Hospital Cancer Center SC Boston, Massachusetts, United States

Novartis Investigative Site Nedlands, Western Australia, Australia

Novartis Investigative Site Salzburg, Austria

View all 23 locations

View Trial Details